Mike Klein

Mike Klein is the CEO of Genomenon, a privately held AI-driven genomics company. Genomenon makes genomic information actionable for diagnosing and treating babies born with rare diseases and cancer patients. The company organizes the world’s genomic knowledge and puts it at the fingertips of clinicians to diagnose patients and pharma researchers to create targeted therapies for genetic diseases.